Related references
Note: Only part of the references are listed.Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: A pharmacological analysis
Klas R. Linderholm et al.
NEUROPHARMACOLOGY (2007)
Increased locomotor response to amphetamine induced by the repeated administration of the selective kappa-opioid receptor agonist U-69593
Jose Antonio Fuentealba et al.
SYNAPSE (2007)
Elevations of endogenous kynurenic acid produce spatial working memory deficits
Amy C. Chess et al.
SCHIZOPHRENIA BULLETIN (2007)
Kynurenic acid has a dual action on AMPA receptor responses
Christina Prescott et al.
NEUROSCIENCE LETTERS (2006)
Increased concentration of cerebral kynurenic acid alters stimulus processing and conditioned responding
Amy C. Chess et al.
BEHAVIOURAL BRAIN RESEARCH (2006)
Subchronic treatment with kynurenine and probenecid: effects on prepulse inhibition and firing of midbrain dopamine neurons
LK Nilsson et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
Effects of COX-1 and COX-2 inhibitors on the firing of rat midbrain dopaminergic neurons - Possible involvement of endogenous kynurenic acid
L Schwieler et al.
SYNAPSE (2006)
Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia
LK Nilsson et al.
SCHIZOPHRENIA RESEARCH (2005)
Nanomolar concentrations of kynurenic acid reduce extracellular dopamine levels in the striatum
A Rassoulpour et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Amphetamine induces dopamine efflux through a dopamine transporter channel
KM Kahlig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients
Kenji Hashimoto et al.
BMC PSYCHIATRY (2005)
Decreased phosphorylation of NMDA receptor type 1 at serine 897 in brains of patients with schizophrenia
ES Emamian et al.
JOURNAL OF NEUROSCIENCE (2004)
Endogenous kynurenic acid disrupts prepulse inhibition
S Erhardt et al.
BIOLOGICAL PSYCHIATRY (2004)
Glutamate as a therapeutic target in psychiatric disorders
DC Javitt
MOLECULAR PSYCHIATRY (2004)
Working memory deficit as a core neuropsychological dysfunction in schizophrenia
H Silver et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Micromolar brain levels of kynurenic acid are associated with a disruption of auditory sensory gating in the rat
PD Shepard et al.
NEUROPSYCHOPHARMACOLOGY (2003)
A microsatellite repealt in the promoter of the N-methyl-D-aspartate receptor 2A subunit (GRIN2A) gene suppresses transcriptional activity and correlates with chronic outcome in schizophrenia
M Itokawa et al.
PHARMACOGENETICS (2003)
Subchronic continuous phencyclidine administration potentiates amphetamine-induced frontal cortex dopamine release
A Balla et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid
S Erhardt et al.
ACTA PHYSIOLOGICA SCANDINAVICA (2002)
Excitatory and inhibitory responses of dopamine neurons in the ventral tegmental area to nicotine
S Erhardt et al.
SYNAPSE (2002)
In vivo modulation of ventral tegmental area dopamine and glutamate efflux by local GABA(B) receptors is altered after repeated amphetamine treatment
M Giorgetti et al.
NEUROSCIENCE (2002)
Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia
S Erhardt et al.
NEUROSCIENCE LETTERS (2001)
Increased cortical kynurenate content in schizophrenia
R Schwarcz et al.
BIOLOGICAL PSYCHIATRY (2001)
N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia
S Dracheva et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review
MA Geyer et al.
PSYCHOPHARMACOLOGY (2001)
Presynaptic kynurenate-sensitive receptors inhibit glutamate release
R Carpenedo et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2001)
Identification of single nucleotide polymorphisms (SNPs) and other sequence changes and estimation of nucleotide diversity in coding and flanking regions of the NMDAR1 receptor gene in schizophrenic patients
SR Rice et al.
MOLECULAR PSYCHIATRY (2001)
Amphetamine-stimulated cortical acetylcholine release: role of the basal forebrain
HM Arnold et al.
BRAIN RESEARCH (2001)
Mutation analysis of the NMDAR2B (GRIN2B) gene in schizophrenia
T Ohtsuki et al.
MOLECULAR PSYCHIATRY (2001)
Interactions between monoamines, glutamate, and GABA in schizophrenia: New evidence
A Carlsson et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
Pharmacological elevation of endogenous kynurenic acid levels activates nigral dopamine neurons
S Erhardt et al.
AMINO ACIDS (2001)
Amphetamine increases glutamate efflux in the rat ventral tegmental area by a mechanism involving glutamate transporters and reactive oxygen species
ME Wolf et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: Implications for schizophrenia
LS Kegeles et al.
BIOLOGICAL PSYCHIATRY (2000)
Share Paper
